The IHC results indicate that the observed tumor growth inhibition during the treatment with prodrug 2 is caused by the reduced cell proliferation and increased cell apoptosis and quiescence, confirming the critical role of PACE4 in tumor progression. Here, PCSK6 is linked to neoplasm.